What Is a GHB Blood Test and How Does It Work?

A GHB blood test measures the concentration of gamma-hydroxybutyric acid in a blood sample, typically using chromatography or an enzymatic screening assay, to determine whether someone has been exposed to the drug. What makes GHB testing uniquely complicated is that your body produces small amounts of GHB on its own, so the lab is not simply looking for the presence of a substance but trying to figure out whether the amount detected exceeds what your body would naturally contain. That distinction between “normal” and “suspicious” is where most of the difficulty lies, and it shapes nearly every aspect of how these tests are performed, interpreted, and used in both clinical and forensic settings.

Why Your Body Already Contains GHB

GHB is not just a street drug or a medication. It is a naturally occurring molecule in the human body, produced as a breakdown product of the neurotransmitter GABA (gamma-aminobutyric acid).¹ Everyone has trace amounts of GHB circulating in their blood, urine, and saliva at all times. In a placebo-controlled clinical trial that established baseline levels, endogenous GHB in blood ranged from about 0.007 to 0.05 micrograms per milliliter, with a median around 0.014. Urine levels ran somewhat higher, and oral fluid concentrations varied even more widely, reaching up to about 0.93 micrograms per milliliter in some individuals.² This natural background means that simply detecting GHB in a blood draw proves nothing. The entire purpose of the test is to measure how much is there and then compare that number against a threshold.

How GHB Leaves the Body So Quickly

GHB is eliminated from the bloodstream faster than almost any other recreational drug. After someone takes a dose, blood levels peak within about 20 to 40 minutes, and the drug’s plasma half-life is roughly 30 to 50 minutes at therapeutic doses.³ Only about 1 to 5 percent of the dose ends up in urine, and the total window of detection in urine after a single dose is roughly 3 to 10 hours.

At larger recreational or abusive doses, though, the body’s elimination machinery gets overwhelmed. Instead of clearing GHB at the usual exponential rate, the system switches to a roughly constant rate of removal, meaning a fixed amount is cleared per hour regardless of how much remains. Research on apprehended drivers in Norway found a median elimination rate of about 21 milligrams per liter per hour under real-world conditions, with substantial person-to-person variation.⁴ Toxicologists have stressed that back-calculating someone’s earlier blood level using simple half-life math can produce wildly wrong numbers at high doses; zero-order elimination models are more realistic in those scenarios.⁵

The practical upshot for anyone seeking testing is that timing is critical. If a blood sample is not drawn within a few hours of exposure, GHB may already have fallen back to endogenous levels, making the test useless for proving ingestion. This narrow window is the single biggest limitation of GHB blood testing and the reason alternative sample types like hair have attracted research interest.

What Happens in the Lab

Laboratories use two broad categories of methods to measure GHB in blood. The first is chromatography-based, and the second is enzymatic screening. They serve different purposes and are often used in sequence.

Chromatographic Methods

The gold standard for GHB measurement is gas chromatography coupled with mass spectrometry (GC-MS or GC-MS/MS). In this process, a small blood sample undergoes chemical preparation: proteins are removed, the GHB molecule is chemically modified to make it easier to detect, and a deuterium-labeled version of GHB is added as an internal reference to ensure accuracy. The prepared sample is then vaporized, separated by its chemical properties as it travels through a long capillary column, and identified by its molecular fragments in the mass spectrometer.

One validated GC-MS/MS method, using just 100 microliters of whole blood (a few drops), achieved a lower limit of quantitation of 0.1 milligrams per liter and could reliably measure GHB across a range from 0.1 to 100 milligrams per liter.⁶ An earlier GC-MS/MS approach using 50 microliters of sample achieved a lower limit of quantitation of 2.5 micrograms per milliliter.⁷ These methods are highly specific, meaning they can distinguish GHB from other chemically similar substances with great reliability. The trade-off is that they require expensive equipment, trained technicians, and hours of preparation time per batch of samples.

Enzymatic Screening

For situations where speed matters more than forensic-level precision, some labs use an enzymatic assay. This approach relies on an enzyme that reacts specifically with GHB, producing a color change that can be measured by a standard clinical chemistry analyzer. The sample preparation is simpler: urine and serum samples need only brief centrifugation, while blood requires an additional step to precipitate proteins.⁸ The throughput is much higher than chromatographic methods, making enzymatic assays practical for emergency department screening and high-volume forensic labs. Positive results, however, are typically confirmed by GC-MS before being reported for forensic or legal purposes. Emergency departments have used this enzymatic approach to screen suspected intoxicated patients and get results much faster than chromatographic turnaround would allow.⁹

Cut-Off Levels and What the Numbers Mean

Because everyone’s blood contains some GHB naturally, labs use cut-off concentrations to distinguish normal from suspicious. The widely used cut-off for antemortem (living-person) blood or serum is 4 to 5 milligrams per liter. Anything below that range is considered potentially endogenous; anything above it suggests outside exposure.¹⁰

A large study measuring GHB in serum and urine samples from people with no known exposure found serum concentrations ranging from about 0.6 to 3.2 milligrams per liter, with a mean of roughly 1.1. The data supported keeping the antemortem serum cut-off at 4 milligrams per liter, while for urine, the researchers proposed lowering the traditional cut-off from 10 milligrams per liter to 6 milligrams per liter to reduce the chance of missing genuine cases of exposure.¹¹

These cut-offs are not perfectly sharp dividing lines. They are practical compromises between catching true positives and avoiding false alarms. A result of 3.5 milligrams per liter in blood could, in theory, represent a very high natural producer or could indicate a dose taken many hours earlier that has mostly cleared. Context always matters: what symptoms did the person have, how long after the suspected exposure was the sample drawn, and was the sample stored properly?

After a controlled single dose of GHB in a research study, urine concentrations fell below the 10-milligram-per-liter cut-off in about 81 percent of samples collected 6 to 12 hours later, and in 100 percent of samples collected after 12 hours.¹² In other words, within half a day of a single dose, most people’s urine would test “negative” under standard cut-offs. Blood clears even faster.

Recent research has suggested that when blood samples are properly preserved with sodium fluoride and stored frozen, endogenous GHB levels remain very low, and the cut-off for distinguishing exogenous use could potentially be set considerably lower than the current 5-microgram-per-milliliter threshold.¹³ Lower cut-offs would extend the effective detection window, catching cases that current thresholds miss, but the field has not yet adopted them broadly.

The Storage Problem

One of the strangest challenges in GHB testing is that GHB concentrations can rise in a blood sample after it has been collected, even when the person never ingested any GHB at all. This happens because bacteria and enzymes in stored blood can generate GHB from precursor molecules over time. The phenomenon is well-documented and has serious implications for forensic work.

In one study, whole blood samples stored at refrigerator temperature or room temperature in liquid form showed meaningful increases in GHB over time. In two of 40 blood samples stored at 4°C for an extended period, GHB concentrations rose to around 13 micrograms per milliliter, which would exceed the standard cut-off and could produce a false-positive result in someone who had never taken the drug.¹⁴ Crucially, the same study found that freezing whole blood or using serum instead of whole blood prevented this artificial rise.

A longer-term investigation examining postmortem samples stored with and without sodium fluoride preservative found a significant increase in GHB concentrations at four weeks and three months after collection, followed by a decline back toward initial values. Adding sodium fluoride, a preservative commonly used to inhibit bacterial activity, did not significantly prevent this increase.¹⁵ Other work, however, found that samples stored frozen at -20°C with fluoride preservatives remained stable for years.¹⁶

The take-home message for anyone involved in forensic or clinical GHB testing is that how a sample is handled after collection can be as important as the analysis itself. A blood sample left at room temperature for days before reaching the lab may tell a misleading story. Proper chain-of-custody protocols, preservative tubes, and frozen storage are not bureaucratic formalities; they are defenses against biochemistry that would otherwise contaminate the evidence.

GHB Testing in the Emergency Department

When someone arrives at an emergency department unconscious, vomiting, or in respiratory distress and drug use is suspected, GHB is one of many possible culprits. But clinical symptoms of GHB overdose, including deep sedation, slow breathing, and low heart rate, overlap heavily with the effects of other sedatives, opioids, and alcohol. In a 12-month study of 146 patients who arrived at a Washington State emergency department with suspected GHB overdose, only about a third actually tested positive for GHB. The remaining two-thirds had similar symptoms from other causes.¹⁷

This finding highlights why laboratory confirmation matters. Clinicians cannot reliably distinguish GHB from other sedative overdoses by appearance alone, and treatment decisions, including whether to suspect drug-facilitated assault, can hinge on what the blood test reveals. Rapid enzymatic screening makes this practical in an emergency setting, though the result will still need chromatographic confirmation if it becomes part of a legal case.

Forensic and Law-Enforcement Applications

GHB has a long history of forensic relevance, both as a recreational drug leading to impaired driving and as a drug used to incapacitate victims of sexual assault. In a large study of blood samples from impaired drivers in Scandinavia, the average GHB concentration was about 90 milligrams per liter, and the offenders were overwhelmingly young men.¹⁸ These concentrations are orders of magnitude above the endogenous range, making interpretation relatively straightforward when a sample is collected at the time of arrest.

The more agonizing forensic scenario is sexual assault. Victims may not be able to report the assault for many hours or even days, by which point GHB has cleared from blood and urine entirely. Researchers have described this detection window as “very short” and noted that proving GHB administration after a rape case is extremely difficult with conventional blood or urine testing.¹⁹ This has driven interest in alternative sample types that might retain evidence of exposure over longer periods.

Hair Testing as a Longer Window

Because blood and urine clear GHB so quickly, forensic researchers have explored hair as a testing matrix. The idea is compelling: as hair grows, substances circulating in the blood get incorporated into the hair shaft, creating a timeline of drug exposure that can be read weeks or months later. Early work demonstrated that a single oral dose of GHB could be detected in hair collected about a month afterward, suggesting the approach had real promise for sexual assault cases.²⁰

Subsequent research has been less encouraging. A study examining hair from narcolepsy patients who took pharmaceutical GHB (sodium oxybate) chronically at high doses found that neither GHB nor its metabolite GHB-glucuronide was reliably detectable in their hair, possibly due to hair treatments like coloring or bleaching. The authors concluded that negative hair results cannot rule out GHB exposure.²¹

The endogenous-versus-exogenous problem also surfaces in hair. GHB is present in hair naturally, so a single-point measurement above some threshold does not necessarily prove outside exposure. Segmental analysis, where the hair is cut into small sections representing different time periods and each section is measured separately, offers a workaround. If one segment shows a spike while adjacent segments show normal levels, that pattern is harder to explain without external administration. Recent work has confirmed that this segmental approach is worth performing in forensic cases, even as the overall reliability of hair testing for GHB remains a subject of debate.²²

Precursor Drugs and What They Mean for Testing

GHB itself is not the only substance that can produce a positive GHB blood test. Two chemical precursors, gamma-butyrolactone (GBL) and 1,4-butanediol (BDO), are converted into GHB by the body after ingestion. GBL converts rapidly and spontaneously, while BDO requires the enzyme alcohol dehydrogenase, the same enzyme that processes drinking alcohol. In a clinical study, volunteers who took BDO reached a mean peak GHB concentration of about 50 micrograms per milliliter under normal conditions. When the alcohol-processing enzyme was blocked by the drug fomepizole, the conversion of BDO to GHB was dramatically suppressed, and peak GHB levels dropped to roughly a fifth of the unblocked value.²³

From a testing perspective, this means a positive GHB blood test does not necessarily mean the person took GHB itself. They may have ingested a precursor. Standard GHB blood tests do not distinguish between GHB taken directly and GHB generated in the body from GBL or BDO. In forensic investigations, if the original substance matters, the lab would need to specifically test for GBL or BDO, which requires a different analytical method. Because GHB is often mixed into alcoholic drinks, researchers have also confirmed that ethanol and its metabolites do not interfere with GHB detection methods, so co-ingestion with alcohol does not produce false results.²⁴

Portable Testing on the Horizon

Nearly all GHB testing today requires a laboratory, whether it is a hospital chemistry analyzer running an enzymatic screen or a forensic lab running GC-MS confirmation. That constraint is a problem when timing is everything. Researchers have been working on portable, point-of-care technologies that could detect GHB on-site, essentially bringing the lab to the patient or the crime scene.

One recently described system uses a lateral flow strip, similar in format to a home pregnancy test, paired with a smartphone camera that reads fluorescence. In testing with diluted urine samples, the device achieved a detection threshold low enough to clearly separate normal endogenous GHB levels from concentrations indicating external intake, and it delivered results within about one minute.²⁵ This kind of rapid, low-cost screening could be transformative for emergency departments and law enforcement if it proves reliable in real-world conditions. It would not replace lab confirmation for legal proceedings, but it could ensure that the right samples are collected early enough for those confirmatory tests to still be useful, rather than hours too late.